The first ‘graduates’ have emerged from a medical accelerator based at Hadassah Hospital Ein Kerem. 

Funded by IBM’s Israel accelerator, IBM Alpha Zone, and supported by the Jerusalem Development Authority, this unique, exciting and transformative project consists of a six months’ program for seed and early-stage medical/technological start-ups, and offers participating companies access to Hadassah’s clinical and research resources, free office space, mentorship and guidance.

Locating the accelerator at Hadassah’s BioHouse workspace, recognises Hadassah’s standing as a giant in medical research in Israel.  More than 50% of all hospital-based medical research occurs at Hadassah, where doctors are encouraged to participate in research ‘from the bedside’.

Tamar Raz, CEO of Hadasit Medical Research Services and Development, a unit that commercializes innovations developed within the hospital, said:

“We seek to maximize the ecosystem of innovation in Hadassah.  The program, the first medical accelerator operated inside a hospital and IBM’s first worldwide, will complement the research being done within the hospital walls.”

Tamar Raz, CEO of the Hadasit Medical Research Services and Development

The aim of the accelerator is to help start-ups develop technologies for the global medical market. The program focuses on early-stage enterprises, at seed and post-seed stage.  The start-ups can enlist doctors and patients to test out their ideas, while the hospital will be able to tap into new technologies at an early stage.

Raz continued: 

“Digital health is a new field, and we wanted to make a link between innovation in this field and Hadassah.  Our long-time vision is to help companies and bring their innovation and new ideas into the hospital. This maximizes our ability to use the technologies earlier.”

Ron Finkel AM, President of Hadassah Australia, said hospitals that are at the forefront of innovation are better positioned to cope with the challenges posed by shortage of staff and budgetary constraints.

He said:

“To be eligible for the program, companies have to be less than five years old, have a ‘strong fit’ with the Hadassah medical ecosystem and with IBM technologies, and have an innovative healthcare solution.”

Among the graduates is MyMilk, which is developing a handheld breast milk scanner that connects with an app that monitors milk quality and production and provides information about the origin of complications including pain and infection.

Other graduates include:

TuneFork.  Its software allows the creation of a personalized audio profile, through a simple hearing test and using algorithms to calculate the optimal frequencies for the user.

Deep Health.  The company is developing an AI-based surgery navigation system, with the first of its products addressing spine surgery.

MDI Health.  Provides data-driven software that can predict how a prescribed medical cocktail is going to affect patients.

Tongo.  Formerly known as Ukappi, is a tongue-based system that enables users to control digital devices without relying on their hands.

Neuroya.  The company has developed an algorithm that optimizes the diagnosis and management of conditions such as ADHD and autism.

The accelerator has already selected start-ups for its second cohort.  These include a company that is developing technology to autonomously identify treatment gaps and errors in medical records, and one that is developing a wearable device that delivers microcurrent electrotherapy for pain reduction.